Valuation: Orthofix Medical Inc.

Market Cap 455M 399M 371M 341M 640M 43.79B 650M 4.41B 1.72B 21.53B 1.71B 1.67B 74.44B P/E 2026 *
-9.57x
P/E 2027 * -12.7x
Enterprise Value 455M 399M 371M 341M 640M 43.79B 650M 4.41B 1.72B 21.53B 1.71B 1.67B 74.44B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.51x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
1 day+2.65%
1 week-2.85%
Current month+23.09%
1 month+20.19%
3 months-8.91%
6 months-15.60%
Current year-25.79%
1 week 10.75
Extreme 10.75
11.81
1 month 8.94
Extreme 8.94
12.04
Current year 8.85
Extreme 8.85
16.42
1 year 8.85
Extreme 8.85
16.99
3 years 8.85
Extreme 8.85
21.6
5 years 8.85
Extreme 8.85
43.3
10 years 8.85
Extreme 8.85
74.44
Manager TitleAgeSince
Chief Executive Officer 54 08/01/2024
Director of Finance/CFO 55 15/01/2024
Compliance Officer - 01/02/2015
Director TitleAgeSince
Director/Board Member 66 16/03/2016
Director/Board Member 54 08/06/2020
Director/Board Member 64 05/01/2023
Date Insider Type Main position Quantity % Market Cap.
18/06/26 Sell

Executive/Senior Manager

-3,670 0.0091%
10/06/26 Free

Director

14,965 0.0370%
10/06/26 Free

Director

14,965 0.0370%
Change 5-day change 1-year change 3-year change Capi.($)
+2.65%-2.85%+0.09%-43.69% 455M
+2.29%+2.36%-17.97%-10.09% 180B
+1.46%+0.01%-9.87%-6.25% 107B
+1.58%+0.65%+6.69%+61.86% 60.29B
-1.13%-2.60%+26.37%+54.76% 50.19B
+2.22%-1.14%-14.85%-44.15% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-17.52%-43.99% 27.61B
-7.67%-8.39%+17.59%-12.73% 23.1B
+1.63%-1.73%-5.80%-7.80% 20.86B
Average +0.75%-2.30%-1.70%-5.79% 54.44B
Weighted average by Cap. +1.28%-0.40%-6.62%+0.80%

Financials

2026 *2027 *
Net sales 843M 741M 689M 632M 1.19B 81.21B 1.21B 8.18B 3.2B 39.93B 3.17B 3.1B 138B 886M 778M 723M 664M 1.25B 85.29B 1.27B 8.59B 3.36B 41.93B 3.32B 3.25B 145B
Net income -46.32M -40.68M -37.83M -34.72M -65.23M -4.46B -66.24M -449M -176M -2.19B -174M -170M -7.58B -36.85M -32.37M -30.1M -27.62M -51.9M -3.55B -52.7M -357M -140M -1.74B -138M -135M -6.03B
Net Debt - -
Logo Orthofix Medical Inc.
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
1,605
Date Price Change Volume
24/07/26 $11.25 +2.65% 238,980
23/07/26 $10.96 -0.54% 181,372
22/07/26 $11.02 -5.25% 197,788
21/07/26 $11.63 +0.61% 417,477
20/07/26 $11.56 -0.17% 463,957
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.25USD
Average target price
15.50USD
Spread / Average Target
+37.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OFIX Stock